can also reduce the risk of stroke and heart attack.So far, intervention trials using medications to improve or increase HDL levels have been unsuccessful.
Also, some genetic research indicates that lifelong high or low levels of HDL do not seem to relate to cardiovascular outcomes, as expected.That is why some cardiovascular risk prevention researchers are shifting their focus from circulating HDL levels to the actual functional ability of HDL.